BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11201114)

  • 21. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial.
    Akasu T; Moriya Y; Ohashi Y; Yoshida S; Shirao K; Kodaira S;
    Jpn J Clin Oncol; 2006 Apr; 36(4):237-44. PubMed ID: 16675478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Surgical treatment of cancer at the beginning of the third millenium--based on the 2004 Krompecher Memorial Lecture of the Society of Hungarian Oncologists].
    Balogh A
    Magy Onkol; 2010 Jun; 54(2):101-15. PubMed ID: 20576585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer.
    Akasu T; Sugihara K; Moriya Y
    Ann Surg Oncol; 2009 Oct; 16(10):2779-86. PubMed ID: 19626377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery.
    Maurer CA; Z'Graggen K; Renzulli P; Schilling MK; Netzer P; Büchler MW
    Br J Surg; 2001 Nov; 88(11):1501-5. PubMed ID: 11683749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Surgery of colorectal carcinoma].
    Becker H
    Praxis (Bern 1994); 1995 Nov; 84(47):1371-2. PubMed ID: 7501917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sphincter-preserving surgery in rectal cancer].
    Belmonte Montes C; Decanini Terán C
    Rev Gastroenterol Mex; 1996; 61(2):124-33. PubMed ID: 8927916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local recurrences and primary surgery in rectal carcinoma.
    Di Matteo G; Maturo A; Redler A; D'Andrea V; Di Matteo FM; Montori J; Peparini N; Zeri KP; Mascagni D
    Panminerva Med; 2000 Sep; 42(3):201-5. PubMed ID: 11218626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Causes of local recurrence after curative surgery for rectal cancer].
    Hôhn J; Varga L; Baradnay G; Simonka Z; Géczi T; Nagy F; Molnár T; Maráz A; Kahán Z; Balogh A
    Magy Onkol; 2003; 47(4):355-9. PubMed ID: 14716430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Different strategies between Japan and other countries for the diagnosis and treatment of rectal cancer].
    Watanabe T
    Nihon Geka Gakkai Zasshi; 2008 Nov; 109(6):338-42. PubMed ID: 19068715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One hundred years of curative surgery for rectal cancer: 1908-2008.
    Lange MM; Rutten HJ; van de Velde CJ
    Eur J Surg Oncol; 2009 May; 35(5):456-63. PubMed ID: 19013050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Total excision of the mesorectum in cancer of the lower and middle rectum. Oncological and functional results].
    Kneist W; Heintz A; Wolf HK; Junginger T
    Chirurg; 2003 Feb; 74(2):125-31. PubMed ID: 12599030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy.
    Morcos B; Baker B; Al Masri M; Haddad H; Hashem S
    Eur J Surg Oncol; 2010 Apr; 36(4):345-9. PubMed ID: 20071133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial.
    Kusters M; Marijnen CA; van de Velde CJ; Rutten HJ; Lahaye MJ; Kim JH; Beets-Tan RG; Beets GL
    Eur J Surg Oncol; 2010 May; 36(5):470-6. PubMed ID: 20096534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rectal carcinoma--oncologically adequate resection].
    Simon D
    Praxis (Bern 1994); 2001 Apr; 90(14):575-80. PubMed ID: 11320884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total mesorectal excision - 40 years of standard of rectal cancer surgery.
    Votava J; Kachlik D; Hoch J
    Acta Chir Belg; 2020 Aug; 120(4):286-290. PubMed ID: 32200705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Informed consent for colorectal cancer surgery].
    Yamaguchi S; Morita H; Ishii M; Saito S
    Nihon Geka Gakkai Zasshi; 2007 Jan; 108(1):15-8. PubMed ID: 17304952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adjuvant radiotherapy in rectal cancer and total mesorectal excision].
    Coco C; Valentini V; Verbo A
    Ann Ital Chir; 2001; 72(5):527-32. PubMed ID: 11975406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rectal cancer--review of methods and treatment results].
    Grotowski M
    Pol Merkur Lekarski; 2004 Mar; 16(93):289-92. PubMed ID: 15190612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.